诚信认证:
工商注册信息已核实!
快速导航
产品分类
微信二维码
Minisite
细胞凋亡
PD0332991 HCl
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
阿拉丁 | 生产商 | 上海 | 现货 |
产品参数
货号 | CAS号 | 操作 |
---|---|---|
E129959-10mg | 827022-32-2 | 询价 |
E129959-250mg | 827022-32-2 | 询价 |
E129959-50mg | 827022-32-2 | 询价 |
E129959-100mg | 827022-32-2 | 询价 |
E129959-5mg | 827022-32-2 | 询价 |
产品介绍
- 分子式 C24H29N7O2·HCl
- 分子量483.99
属性
溶解性 | Soluble in water (30 mg/ml at 25 °C), DMSO (3 mg/ml at 25 °C), and ethanol (< 1 mg/ml at 25 °C). |
存贮条件 | 储存温度-20°C |
描述
应用 | A highly selective inhibitor of Cdk4/cyclin D1 and Cdk6/cyclin D2. |
产品介绍 | Palbociclib (PD-0332991) HCl是一种高度选择性的CDK4/6抑制剂,IC50为11 nM/16 nM,对CDK1/2/5, EGFR, FGFR, PDGFR, InsR等没有抑制活性。Phase 3。 |
备注 | PD0332991 is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 2/3. |
生化机理 | PD 0332991 is a highly selective inhibitor of Cdk4/cyclin D1 and Cdk6/cyclin D2 (IC50’s: Cdk4 = 11 nM; Cdk6 = 16 nM). PD 0332991 has little effect on other protein kinases including EGFR, FGFR, PGFR, and IR. PD 0332991 is a non-ATP competitive inhibitor of Cdk4. PD 0332991 inhibits MDA-MB-435 breast carcinoma cells (IC50 = 66 nM), which is due to reduced Rb phosphorylation at Ser780. PD 0332991 inhibits thymidine incorporation into the DNA of Rb-positive human breast, colon, and lung carcinomas as well as human leukemias. PD 0332991 shows no activity in Rb-negative cells. PD 0332991 inhibits luminal ER-positive as well as HER2-amplified breast cancer cell lines. PD 0332991 enhances the sensitivity of tamoxifen in the MCF7 tamoxifen-resistant cells. A recent study shows that PD 0332991 could also suppress malignant rhabdoid tumor (MRT) cell lines. |
别名 | 6-乙酰基-8-环戊基-5-甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]吡啶并[2,3-d]嘧啶-7(8H)-酮盐酸盐;Palbociclib hydrochloride;Palbociclib HCl; PD-0332991 hydrochloride; PD0332991 hydrochloride; PD 0332991 hydrochloride;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride;Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-, monohydrochloride |
PD0332991 HCl信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于PD0332991 HCl报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途